Preparation, characterization, solubilization and antioxidant activity of polyamine modified β-cyclodextrins with baicalein inclusion complexes

Novel succinoglycan dialdehyde/aminoethylcarbamoyl-β-cyclodextrin hydrogels for pH-responsive delivery of hydrophobic drugs

β-Cyclodextrin cross-linked succinoglycan dialdehyde hydrogels was prepared for hydrophobic drug delivery. Succinoglycan dialdehyde (SGDA) was synthesized from sodium periodate oxidation of succinoglycan isolated from Sinorhizobium meliloti Rm1021. Aminoethylcarbamoyl-β-cyclodextrin (ACD) was crosslinked with SGDA to form a succinoglycan dialdehyde/aminoethylcarbamoyl-β-cyclodextrin (SGDA/ACD) hydrogels. The SGDA/ACD hydrogels exhibited a 65.7 % improvement in storage modulus (G') and a 5.7-fold higher compressive strain than the SGDA/poly(ethylene glycol) diamine (PEG) hydrogels as controls. A hardly soluble drug, baicalein was used for the drug loading and release properties of SGDA/ACD hydrogels. Baicalein was released about 98 % within 48 h at pH 7.4, but not completely released even after 48 h at pH 2.0. In addition, at pH 7.4, only about 56 % of the baicalein loaded on the SGDA/PEG hydrogels was released within 48 h, while about 98 % of the baicalein loaded on the SGDA/ACD hydrogels was released within 48 h. It indicates that ACD significantly improved the solubilization efficacy of the baicalein. In vitro testing of cell viability using HEK-293 cells also showed that the SGDA/ACD hydrogels were suitable for the cells. In conclusion, SGDA/ACD hydrogels significantly enhance the utilization of baicalein and provide potential applications in drug delivery systems for hardly soluble drugs.

Cannabidiol/hydroxypropyl-β-cyclodextrin inclusion complex: structure analysis, release behavior, permeability, and bioactivity under in vitro digestion

The inclusion complex of CBD greatly improved its release performance and bioactivity.

Experimental and molecular docking investigation of the inclusion complexes between 20(S)-protopanaxatriol and four modified β-cyclodextrins

20(S)-Protopanaxatriol (PPT) is a type of ginsenoside isolated from panax notoginseng or ginseng, which is an essential ingredient in functional food, healthcare products and traditional medicine. However, the research and development of PPT are restricted due to its poor solubility. To circumvent the associated problems, a novel bridged-bis [6-(2,2'-(ethylenedioxy) bis (ethylamine))-6-deoxy-β-CD] (H4) was successfully synthesized. The four inclusion complexes of the mono-[6-(1,4-butanediamine)-6-deoxy-β-CD] (H1), mono-[6-(2,2'-(ethylenedioxy) bis (ethylamine)-6-deoxy-β-CD] (H2) and their corresponding bridged bis(β-CD)s (H3, H4) with PPT were prepared and studied by UV, ¹H NMR, 2D ROESY, FT-IR, XRD and SEM technology. The UV-spectrometric titration showed that H1-4 and PPT formed 1:1 inclusion complexes and the binding constants were 297.61, 322.25, 937.88 and 1742 M^-1, respectively. It was further revealed that the size/shape-matching relationship, hydrophobic interactions and hydrogen bond interactions play the crucial role in determining the stability of H1-4/PPT inclusion complexes. The solubility of PPT was evidently enhanced by193, 265, 453 and 593 times after the formation of inclusion complexes with H1-4, respectively. Furthermore, molecular docking was used to verify the inclusion mode of H4/PPT inclusion complex and also to investigate the stability of H4/PPT in water phase. The molecular simulation results agreed well with the experimental results. This research provides an effective way to obtain novel PPT-based functional food and healthcare products.

Macrocycles and Supramolecules as Antioxidants: Excellent Scaffolds for Development of Potential Therapeutic Agents

Oxidative stress due to the high levels of reactive oxygen species (ROS) that damage biomolecules (lipids, proteins, DNA) results in acute inflammation. However, without proper intervention, acute inflammation progresses to chronic inflammation and then to several chronic diseases, including cancer, myocardial infarction, cardiovascular diseases, chronic inflammation, atherosclerosis, and more. There has been extensive research on the antioxidants of natural origin. However, there are myriad possibilities for the development of synthetic antioxidants for pharmacological applications. There is an increasing interest in the identification of novel synthetic antioxidants for the modulation of biochemical processes related to ROS. In this regard, derivatives of supramolecules, such as calix[n]arene, resorcinarene, calixtyrosol, calixpyrrole, cucurbit[n]uril, porphyrin etc. are gaining attention for their abilities to scavenge the free radicals. Supramolecular chemistry offers excellent scaffolds for the development of novel antioxidants that can be used to modulate free radical reactions and to improve the disorders related to oxidative stress. This review focuses on the interdisciplinary approach for the design and development of novel synthetic antioxidants based on supramolecular scaffolds, with potentially protective effects against oxidative stress.